Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)

  • Susan Stienen
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • João Pedro Ferreira
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Masatake Kobayashi
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Gregoire Preud’homme
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Daniela Dobre
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Jean-Loup Machu
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Kevin Duarte
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Emmanuel Bresso
    Equipe CAPSID, LORIA (CNRS, Inria NGE, Université de Lorraine), Vandoeuvre-lès-Nancy, France;
  • Marie-Dominique Devignes
    Equipe CAPSID, LORIA (CNRS, Inria NGE, Université de Lorraine), Vandoeuvre-lès-Nancy, France;
  • Natalia López
    Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain;
  • Nicolas Girerd
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Svend Aakhus
    Department of Cardiology and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway;
  • Giuseppe Ambrosio
    Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy;
  • Hans-Peter Brunner-La Rocca
    Department of Cardiology, Maastricht University Medical Center, Maastricht, the Netherlands;
  • Ricardo Fontes-Carvalho
    Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Porto, Portugal;
  • Alan G. Fraser
    Wales Heart Research Institute, Cardiff University, Cardiff, UK;
  • Loek van Heerebeek
    Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands;
  • Stephane Heymans
    Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands;
  • Gilles de Keulenaer
    Laboratory of Physiopharmacology, Antwerp University, and ZNA Hartcentrum, Antwerp, Belgium;
  • Paolo Marino
    Clinical Cardiology, Università del Piemonte Orientale, Department of Translational Medicine, Azienda Ospedaliero Universitaria “Maggiore della Carità”, Novara, Italy;
  • Kenneth McDonald
    School of Medicine and Medical Sciences, St Michael’s Hospital Dun Laoghaire Co. Dublin, Dublin, Ireland;
  • Alexandre Mebazaa
    Department of Anaesthesiology and Critical Care Medicine, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France;
  • Zoltàn Papp
    Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary;
  • Riccardo Raddino
    Department of Cardiology, Spedali Civili di Brescia, Brescia, Italy;
  • Carsten Tschöpe
    Department of Cardiology, Campus Virchow-Klinikum, C, Harite Universitaetsmedizin Berlin, Berlin Institute of Health – Center for Regenerative Therapies (BIH-BCRT), and the German Center for Cardiovascular Research (DZHK; Berlin partner site), Berlin, Germany;
  • Walter J. Paulus
    Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, Amsterdam, the Netherlands
  • Faiez Zannad
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;
  • Patrick Rossignol
    CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d’Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France;

収録刊行物

  • Biomarkers

    Biomarkers 25 (2), 201-211, 2020-02-16

    Informa UK Limited

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ